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Ghanaian Women Naturally Exposed to Malaria Parasites
Paulina Ampomah,a Liz Stevenson,a Michael F. Ofori,b Lea Barfod,a Lars Hviida
Centre for Medical Parasitology, University of Copenhagen and Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmarka; Noguchi Memorial Institute for
Medical Research, University of Ghana, Accra, Ghanab
Protective immunity to Plasmodium falciparummalaria acquired after natural exposure is largely antibody mediated. IgG-spe-
cific P. falciparum EMP1 (PfEMP1) proteins on the infected erythrocyte surface are particularly important. The transient anti-
body responses and the slowly acquired protective immunity probably reflect the clonal antigenic variation and allelic polymor-
phism of PfEMP1. However, it is likely that other immune-evasive mechanisms are also involved, such as interference with
formation andmaintenance of immunological memory. Wemeasured PfEMP1-specific antibody levels by enzyme-linked immu-
nosorbent assay (ELISA) andmemory B-cell frequencies by enzyme-linked immunosorbent spot (ELISPOT) assay in a cohort of
P. falciparum-exposed nonpregnant Ghanaian women. The antigens used were a VAR2CSA-type PfEMP1 (IT4VAR04) with ex-
pression restricted to parasites infecting the placenta, as well as two commonly recognized PfEMP1 proteins (HB3VAR06 and
IT4VAR60) implicated in rosetting and not pregnancy restricted. This enabled, for the first time, a direct comparison in the same
individuals of immune responses specific for a clinically important parasite antigen expressed only during well-defined periods
(pregnancy) to responses specific for comparable antigens expressed independent of pregnancy. Our data indicate that PfEMP1-
specific B-cell memory is adequately acquired even when antigen exposure is infrequent (e.g., VAR2CSA-type PfEMP1). Further-
more, immunological memory specific for VAR2CSA-type PfEMP1 can be maintained for many years without antigen reexpo-
sure and after circulating antigen-specific IgG has disappeared. The study provides evidence that natural exposure to P.
falciparum leads to formation of durable B-cell immunity to clinically important PfEMP1 antigens. This has encouraging impli-
cations for current efforts to develop PfEMP1-based vaccines.
Protective immunity to Plasmodium falciparum malaria ac-quired after natural exposure is mediated to a large extent by
IgG antibodies targeting the asexual blood stages of the parasites
(reviewed in reference 1). The low rate of acquisition probably
reflects the extensive clonal antigenic variation and allelic poly-
morphism of key antigens. However, other immune-evasive
mechanisms may also be involved, such as interference with
formation and maintenance of immunological memory. In-
deed, it has often been speculated that such subversion is im-
portant for the slow and incomplete acquisition of clinical pro-
tection following natural exposure to P. falciparum in areas
where these parasites are stably transmitted (reviewed in refer-
ences 2, 3, and 4). The evidence supporting the hypothesis of a
fragile or dysfunctional immunological memory to P. falciparum
includes the often transient IgG responses in childrenwithmalaria
(5–9), apparent interference with antigen presentation (10, 11),
“masking” of surface-exposed IgG epitopes (12), and expansion of
“atypical” or “exhausted” B cells after prolonged exposure to P.
falciparum antigens (13, 14). Conversely, the hypothesis is chal-
lenged by recent evidence that P. falciparum-specific B-cell mem-
ory can be acquired efficiently and maintained for extended peri-
ods in the absence of exposure (15–17) and by data suggesting that
“atypical” P. falciparum-specific memory B cells are not function-
ally “exhausted” (18).
The present study was designed to provide further and more
direct evidence regarding the relationship between exposure to P.
falciparum antigens, antibody levels, and immunological mem-
ory. To that end, we used an approach not previously employed.
Rather than comparing individuals with and without P. falcipa-
rum exposure (which makes it difficult to control for confound-
ers), we recruited a single cohort of nonpregnant women living in
an area with stable P. falciparum transmission.Within this cohort,
we compared antibody levels and memory B-cell frequencies spe-
cific for a parasite protein that is expressed only during pregnancy
to those for similar antigens not restricted in this way. More spe-
cifically, we compared responses to the VAR2CSA-type P. falcip-
arum EMP1 (PfEMP1) protein IT4VAR04 (19) and responses
specific for two other PfEMP1 proteins, HB3VAR06 (20) and
IT4VAR60 (also known as PAR or FCR3S1.2VAR2) (21). The
PfEMP1 proteins constitute an 60-member family of clonally
variant P. falciparum antigens that are expressed in a mutually
exclusive manner on the surfaces of P. falciparum-infected eryth-
rocytes (IEs), where they act as ligands for a range of host receptors
in the vasculature (22–25). PfEMP1 proteins are thus responsible
for the characteristic ability of IEs to adhere in various tissues and
organs, which confers particular virulence to this parasite species
(reviewed in reference 26). VAR2CSA-type PfEMP1 proteins me-
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diate sequestration of IEs to chondroitin sulfate A (CSA) (27, 28),
and many lines of evidence show that this type of PfEMP1 is ex-
pressed only by parasites sequestered in the placenta and that
VAR2CSA is the target of acquired protective immunity to placen-
tal malaria (reviewed in reference 29). In contrast, HB3VAR06
and IT4VAR60 are both involved in rosetting, an adhesion phe-
notype that is linked to severe P. falciparum malaria in children
(reviewed in reference 30). As a probable consequence of this,
anti-rosetting IgG seems to be an important component of ac-
quired protective immunity to severe malaria during childhood
(31). Both HB3VAR6 and IT4VAR60 are encoded by typical
group A var genes. It has long been recognized that certain anti-
genic variants are “common” and immunologically “well-recog-
nized” (32, 33) and that this phenotype is linked to transcription
of group A var genes and expression of the PfEMP1 proteins en-
coded by these genes (34–36). We provide direct evidence that
B-cell memory to the clinically important PfEMP1 antigens is in-
duced and can be maintained for years without reexposure (at
least for VAR2CSA-type PfEMP1) and that circulating IgG is not a
reliable indicator of PfEMP1-specific B-cell memory status. These
findings have important implications for our understanding of
immunity toP. falciparummalaria in general, and for the efforts to
develop PfEMP1-based vaccines against this disease in particular.
MATERIALS AND METHODS
Study site and study participants. The study was conducted in Assin
Foso, located in a rainforest area approximately 80 km north of Cape
Coast, the capital of Central Region, Ghana. Generally, transmission of P.
falciparum parasites remains high in this country (37), and our study area
has been characterized as having intense transmission of P. falciparum
parasites, with limited seasonal variation (38, 39). Although transmission
appears to have declined in recent years (40), malaria remains a serious
health problem in the area.
We studied 104 adult, nonpregnant women, who consented in writing
to participate after receiving an explanation of the study design and pur-
pose. Anamnestic information (age, number of previous pregnancies,
time since last pregnancy, malaria prophylaxis while pregnant, and use of
insecticide-impregnated bed nets) and a venous blood sample were ob-
tained from all participants (Table 1). Ten parturient women from the
same area were included as positive controls, and 13Danish womenwith-
out visits to areas where P. falciparum is endemic were included as nega-
tive controls. The studywas approved by the Institutional ReviewBoard of
Noguchi Memorial Institute for Medical Research, University of Ghana
(study 038/10-11), and by the Regional Research Ethics Committees,
Capital Region of Denmark (protocol H-4-2013-083).
Blood sample collection and preparation. Venous blood samples (8
ml) from theGhanaian donors were collected in heparinized tubes during
the major rainy season (July-August) of 2011. Peripheral bloodmononu-
clear cells (PBMC) were separated by gradient centrifugation on Lym-
phoprep (StemCell Technologies, Grenoble, France) and were cryopre-
served in liquid nitrogen by use of a controlled-gradient freezing device as
described in detail previously (41). Plasma was stored at 20°C. The
presence of P. falciparum asexual-blood-stage parasitemia at the time of
blood sampling was determined by microscopic examination of Giemsa-
stained blood smears.
Antigens. Recombinant proteins representing the entire ectodomains
of three PfEMP1 proteins were produced in baculovirus-infected insect
cells, essentially as described elsewhere (19; L. Stevenson et al., unpub-
lished data). In brief, the ectodomain-encoding parts of the it4var04,
hb3var06, and it4var60 genes (encoding amino acids Met1 to Gln2,644,
Met1 to Cys2,958, andMet1 to Ser2,136, respectively) (see http://genome
.cbs.dtu.dk/services/VarDom/ for sequence data) were codon optimized
for insect cells byGeneArt (Life Technologies BV,Nærum,Denmark) and
thenwere expressed inHigh Five cells. The full-length proteins IT4VAR04
(FV2), HB3VAR06 (FV6), and IT4VAR60 (FV60) were harvested from
supernatants and purified on a Ni2 metal-chelation agarose column
(HisTrap HP; GE Healthcare). Tetanus toxoid (TT) was purchased from
Statens Serum Institut (Copenhagen,Denmark) and used as a nonmalaria
control antigen.
Plasma IgG antibody measurements by ELISA. Plasma levels of IgG
with specificity for FV2, FV6, and FV60 were measured by enzyme-linked
immunosorbent assay (ELISA), essentially as described elsewhere (27). In
brief, 96-well flat-bottomed Nunc microtiter plates (Thermo Scientific,
Waltham, MA) were coated with antigen in Dulbecco’s phosphate-buff-
ered saline (PBS; Lonza, Vallensbæk Strand, Denmark) (pH 7.2, 4°C,
overnight) and blocked (1 h, room temperature) with dilution buffer
(29.2 gNaCl, 0.2 gKCl, 0.2 gKH2PO4, 0.92 gNa2HPO4, 10 g bovine serum
albumin [BSA], 10ml TritonX-100, 1ml phenol red, 1 liter distilledwater
[pH 7.3]). Plasma samples diluted 1:400 (FV2), 1:200 (FV6), 1:120
(FV60), or 1:800 (TT) were added to triplicate wells and incubated (1 h,
room temperature). Optimal plasma dilutions for detection of IgG spe-
cific for each antigen were determined from 2-fold titrations of samples
with known low or high IgG reactivity. Wells were washed in washing
buffer (the same as dilution buffer, but without BSA [pH7.2]), and bound
antibody was detected with horseradish peroxidase (HRP)-conjugated
rabbit anti-human IgG (1:3,000) (Dako, Glostrup, Denmark) followed by
o-phenylenediamine (Sigma-Aldrich, Copenhagen,Denmark). The enzy-
matic reaction was stopped by addition of 2.5MH2SO4 (100l/well), the
optical density (OD) was read at 492 nm, and the specific antibody level
was calculated in arbitrary units (AU) [(ODSAMPLE  ODBLANK)/
(ODPOSCTRL ODBLANK)], essentially as described elsewhere (42). Spe-
cifically, we included samples from two individual Ghanaian donors as
positive-control samples in all ELISA plates. One sample (PF1034) had
high IgG reactivities to FV2, FV6, and TT, whereas the other (NF022) had
high reactivity to FV60. Antibody levels above the mean level in negative-
control samples plus 2 standard deviations (SD)were considered positive.
Memory B-cell frequency determination by ELISPOT assay. Cryo-
preserved PBMCwere thawed in a water bath (37°C), washed in complete
medium (RPMI 1640 supplementedwith 10% fetal bovine serum [FBS], 4
mM L-glutamine, and 20 IU/ml PenStrep), and adjusted to 2.5  106
cells/ml. The cells were then incubated (37°C, 5% CO2, 72 h) in complete
medium in the presence of interleukin-2 (IL-2) (Ness-Ziona, Israel) and
the polyclonal activator R-848 (Invivogen, Toulouse, France). Enzyme-
linked immunosorbent spot (ELISPOT) assay plates (Merck Millipore,
TABLE 1 Characteristics of study participants
Parameter
Value
Exposed,
nonpregnant
women
Exposed,
parturient
women
Nonexposed,
nonpregnant
women
No. of donors 104 10 13
Age (yr)a 29 (17 to 54) 29 (18 to 35) 37 (23 to 54)
No. of pregnanciesa 2 (0 to 11) 2 (1 to 4) 2 (0 to 4)
Time (yr) since last
pregnancya
2 (1 to 20)b 3 (1 to 26)
Proportion parasitemic at
sampling
0.12 0.10
Proportion with malaria
during pregnancyc
0.58b 0.30
Proportion with malaria
prophylaxis during
pregnancyc
0.66b 0.80
Proportion with ITN usec 0.60 0.60
a Data are medians (ranges) and were self-reported.
b Excluding 22 self-reported nulligravidae.
c Self-reported (for most recent pregnancy) ITN, insecticide-treated bed net.
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Hellerup, Denmark) were prewetted (50 l of 70% ethanol, 30 s) and
washed 5 times in distilledwater. FV2, FV6, FV60, or TT (5g/ml, 100l)
was added to each well, and the plates were incubated overnight (4°C).
Plates were then washed 5 times in PBS and blocked with complete me-
dium (1 h, room temperature). Precultured PBMC (see above) were
washed twice in complete medium and seeded in duplicate ELISPOT
assaywells (100l/well). The plates were incubated (37°C, 5%CO2, 24 h),
washed 5 times in PBS, and developed with HRP-conjugated rabbit anti-
human IgG (1:3,000; Dako, Glostrup, Denmark) followed by 3,3=,5,5=-
tetramethylbenzidine (Mabtech, Nacka Strand, Sweden). The plates were
finallywashedunder running tapwater anddried in the dark. The number
of spots was determined with an ImmunoSpot reader (CTL-Europe,
Bonn, Germany). The limited number of cells available precluded accu-
rate determinations of very low frequencies of antigen-specific antibody-
secreting cells.We therefore used a negative cutoff of one antibody-secret-
ing cell per million PBMC, based on the observed frequency of spots
among the negative-control donors (one or two spots in 10% of sam-
ples, indicating a frequency of spot-forming cells in these donors of2
107).
Statistical analysis. Differences in median antibody levels between
donor groups were tested by theMann-Whitney rank sum test. Parameter
associations were tested by Kruskal-Wallis one-way analysis of variance
on ranks. Correlations were tested by Spearman rank-order correlation,
using actual values, whether above or below the negative cutoff. Confi-
dence intervals for proportions were calculated as described previously
(43). P values of0.05 were considered statistically significant.
RESULTS
Plasma levels of PfEMP1-specific IgG and P. falciparum expo-
sure. Plasma levels of antigen-specific (including PfEMP1-spe-
cific) IgG are a measure of previous exposure to that antigen or to
a similar, cross-reactive antigen(s) (44, 45). In accordance with
this, we found that themedian levels of IgG specific for the recom-
binant PfEMP1 antigens FV6 and FV60weremuch higher in plas-
mas from Ghanaian women naturally exposed to P. falciparum
than in plasmas from women without exposure to these parasites
(negative-control donors), indicating the regular exposure of the
Ghanaian women to P. falciparum parasites (Fig. 1). Levels were
unaffected by pregnancy status among the P. falciparum-exposed
women (Fig. 1). Using a negative-cutoff value of the mean plus 2
standard deviations for plasma levels in the negative-control do-
nors, 99% (95% confidence interval, 95% to 100%) and 89%
(82% to 94%) of the P. falciparum-exposed nonpregnant women
in our cohort had above-cutoff levels of FV6- and FV60-specific
IgG, respectively.
In contrast, the median level of IgG specific for the VAR2CSA-
type FV2 antigen was only marginally higher in plasmas from the
nonpregnant cohort women than in plasmas from the negative
controls (Fig. 1). The median level of FV2-specific IgG in plasma
from the P. falciparum-exposed nonpregnant women was mark-
edly lower than that in plasma from positive controls (pregnant
women at delivery) (Fig. 1). Overall, only 36% (27% to 45%) of
the nonpregnant women had levels above the negative cutoff,
compared to 70% (40% to 89%) of the P. falciparum-exposed
control women at the time of delivery. Together, these findings
support earlier observations that expression of VAR2CSA-type
PfEMP1 proteins is restricted to pregnancy (27, 46) and that IgG
with this antigen specificity decline fairly rapid after delivery (47,
48). Two women reporting to be nulligravidae had FV2-specific
IgG levels above the negative cutoff. It seems most likely that they
had in fact been (unsuccessfully) pregnant previously, but they
either did not know or did not remember.
The large majority of women from all three categories of
women studied (P. falciparum-exposed nonpregnant women, P.
falciparum-exposed pregnant women at delivery [positive con-
trols], and nonpregnant women without P. falciparum exposure
[negative controls]) had high plasma levels of IgG specific for the
P. falciparum-unrelated control antigen TT (Fig. 1). The particu-
larly high levels in the positive-control womenprobably reflect the
fact that many had recently received the prophylactic TT booster
vaccination that is a standard part of antenatal care in Ghana.
These data confirm the usefulness of PfEMP1-specific IgG levels as
markers of exposure (49), the existence of interclonally conserved
antibody epitopes in PfEMP1 proteins from genotypically distinct
P. falciparum parasites (50), and the often transient nature of
PfEMP1-specific IgG responses (in the absence of regular reexpo-
sure) (5–9).
Plasma levels ofPfEMP1-specific IgG, age, and time since last
pregnancy. Levels of P. falciparum-specific (including PfEMP1-
specific) IgG increase with age, generally plateau at adolescence,
and may even decline in older age groups (44, 49). In agreement
with this, we did not find a significant correlation between
PfEMP1-specific IgG levels and age in the current study, which
included only adults (Fig. 2). IEs sequestered in the placenta ad-
here selectively to CSA in the intervillous space (51–53). This ad-
FIG 1 Plasma levels of antigen-specific IgG in different groups of women.
Levels of antigen-specific IgG in plasmas from P. falciparum-exposed non-
pregnant (; E) and parturient (Œ; EP) women and from nonexposed, non-
pregnant women (Œ; N) are shown. Individual plasma levels of IgG with
specificity for the P. falciparum antigens FV2, FV6, and FV60 and the non-P.
falciparum antigen tetanus toxoid (TT) are shown. Median levels (horizontal
lines) and their 95%confidence intervals (error bars) are also indicated. Values
are expressed as arbitrary units (AU) (see Materials and Methods for details).
Significant intergroup differences are indicated by lines along the top of the
diagram. The asterisks indicate the level of statistical significance (*, P 0.05;
**, P  0.01; ***, P  0.001). The x axis breaks indicate that levels of IgG
specific for the different antigens are not directly comparable. Shaded areas
indicate values below the negative cutoff.
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hesion ismediated byVAR2CSA-type PfEMP1 (27, 28), and avail-
able evidence overwhelmingly supports the hypothesis that
expression of this PfEMP1 type is restricted to parasites infecting
pregnant women (reviewed in reference 29). In the present study,
22 of the 104 P. falciparum-exposed but nonpregnant women
reported not having been pregnant previously (nulligravidae). Ac-
cordingly, these 22 women should probably be considered nonex-
posed with respect to FV2, but the relationship between FV2-
specific IgG and age remained statistically insignificant after
exclusion of nulligravidae. When we considered only the 37
women who did have positive FV2 responses, a borderline signif-
icant positive association between age and FV2-specific IgG re-
sponses was found [P(rs 0.27) 0.07]. It seems likely that this
reflects that age is a crudemarker of the number of previous preg-
nancies.
In the plasmas of pregnant women, a positive association be-
tween antibody levels and parity is a well-established hallmark of
IgG specific for VAR2CSA-type PfEMP1 (reviewed in reference
29). We reported previously that levels of IgG with specificity for
CSA-adhering IEs decline within a few months after delivery,
whereas levels of IgG specific for IEs not adhering to CSA do not
(48). Supporting this observation, levels of IgG specific for the two
studied PfEMP1 proteins not related to pregnancy (FV6 and
FV60) were not related to time since last pregnancy (Fig. 3). How-
ever, in contrast to our expectation, we did not find a statistically
significant negative association between FV2-specific IgG levels
and time since last pregnancy (Fig. 3). Either our study was un-
derpowered to detect such an association (because a proportion of
the studied womenmight not have been infected by P. falciparum
parasites during their latest pregnancy) or the rate of decline is
actually lower than originally anticipated. Supporting the former
hypothesis, we found that the proportion of women withmeasur-
able FV2-specific IgG did decline with time since delivery [P(rs
0.61) 0.03], whereas this was not the case for the pregnancy-
unrelated PfEMP1 antigens FV6 and FV60 (Fig. 3).
Plasma levels of PfEMP1-specific IgG and parity. Among P.
falciparum-exposed pregnant women, there is a well-documented
association between parity and levels at the time of delivery of IgG
specific for the VAR2CSA-type PfEMP1 (reviewed in reference
29).We found a similar association [P(rs 0.36) 0.001] among
the P. falciparum-exposed women studied here (Fig. 4), although
they were not pregnant at the time of study, and many had not
been pregnant for a long time (Fig. 3). To the best of our knowl-
edge, such an association, which was absent for the two PfEMP1
proteins unrelated to pregnancy (Fig. 4), has not been reported
before. It supports the above-mentioned hypothesis that the rate
of decline in antibodies specific for VAR2CSA-type PfEMP1 fol-
lowing delivery is actually lower than we originally proposed (48).
Frequencies of PfEMP1-specific memory B cells and specific
antigen exposure. It has often been speculated that P. falciparum
is able to subvert the acquisition of immunological memory and
that this is central to the sluggish development of clinical immu-
FIG 2 Relationship between plasma IgG levels and age in nonpregnant Gha-
naian women. Ages and IgG levels specific for FV2 (top), FV6 (center), and
FV60 (bottom) in individual donors are shown, as well as the linear regression
lines and 95% confidence intervals for their relationship. The negative cutoff
(mean plus 2 SD of levels in negative-control donors) is indicated by shading.
With respect to FV2, nonexposed donors (nulligravidae) are indicated with
open symbols.
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nity to malaria and to the transience of P. falciparum-specific an-
tibody responses (2–4).We found that the frequencies ofmemory
B cells capable of transforming into antibody-secreting cells fol-
lowing in vitro stimulationwere similar for all the studied antigens
(Fig. 5). With respect to the PfEMP1 antigens, frequencies among
the P. falciparum-exposed donors did not reflect whether antigen
exposure was infrequent (FV2) or not (FV6 and FV60). In both
cases, a sizeable proportion of the donors had frequencies below
the negative cutoff. It is unlikely that this reflects a lack of exposure
to P. falciparum parasites in general, since all donors were perma-
nent residents of an area with stable parasite transmission. In-
stead, it may reflect a lack of exposure to the specific PfEMP1
antigens used. For FV2, this is supported by the observation that a
large proportion of the donors with frequencies below the nega-
tive cutoff were nulli- or primigravidae. This explanation obvi-
ously does not apply to FV6 and FV60, which are not restricted to
pregnancy. An alternative or additional possibility is that long-
lived, bone-marrow-resident plasma cells are the main source of
circulating antibody, rather than the circulating memory B cells
we measured (54). This hypothesis is supported by our finding
that many more donors had detectable FV6- and FV60-specific
IgG (Fig. 1) than had detectable memory B cells specific for these
antigens (Fig. 5). Finally, we set the negative cutoff based on data
from only 500,000 PBMCdue to the limited number of cells avail-
able for analysis. The stochastic nature of the ELISPOT assay
makes it difficult to determine low frequencies of responding cells
accurately. Thus, it is possible that some of the P. falciparum-
exposed donors with levels below the negative cutoff did in fact
have higher specific antibody-secreting cell frequencies than the
unexposed control donors. With respect to TT, frequencies of
memory B cells were high and similar in all donor groups.
PfEMP1-specific memory B cells and time since last antigen
exposure. Memory B cells for VAR2CSA-type PfEMP1 could be
detected for up to 20 years after the last pregnancy, and the fre-
quency of these cells remained stable over this period (Fig. 6). The
average frequency ofmemoryB cells did not increasewith increas-
ing parity for any of the PfEMP1 antigens (Fig. 7), although the
proportion of women with FV2-specific memory B-cell frequen-
cies above the negative cutoff did increase with parity [P(rs 
0.86) 0.001]. The sustained presence of FV2-specificmemory B
cells many years after the last pregnancy implies that maintenance
of PfEMP1-specific immunological memory does not require reg-
ular exposure to antigen, given that essentially all available evi-
dence indicates that expression of VAR2CSA-type PfEMP1 pro-
teins is restricted to pregnancy (29). Furthermore, the finding that
the frequency of FV2-specific memory B cells did not depend on
parity suggests that exposure to VAR2CSA-type PfEMP1 proteins
over the course of a single pregnancy may be sufficient to induce
affinity maturation, class switching, and induction of long-term
sustainable immunological memory. Even though switching to
FIG 3 Relationship between plasma IgG levels and time since last pregnancy
in nonpregnant Ghanaian women. Times since last pregnancy and IgG levels
specific for FV2 (top), FV6 (center), and FV60 (bottom) in individual donors
are shown, as well as the linear regression lines and 95% confidence intervals
for their relationship. The negative cutoff (meanplus 2 SDof levels in negative-
control donors) is indicated by shading. Note that nulligravidae were excluded
from this graph. The proportions of womenwith FV2-specific IgG levels above
the negative cutoff at different time points are shown in the inset (all time
points where proportion is zero are indicated as 0.01 for visibility only).
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VAR2CSA-type PfEMP1 proteins appears to be noncompatible
with parasite survival in in nonpregnant hosts, women already
primed with these antigens during earlier pregnancies may also
contribute to long-term sustaining of VAR2CSA-specific immu-
nological memory. Several women who claimed not to have been
pregnant before did have levels of FV2-specific memory B cells
above the negative cutoff (Fig. 7, top panel). We have no convinc-
ing explanation for this. The simplest reason is that these women
had in fact been pregnant previously, but they either did not know
or did not remember it.
Relationship between PfEMP1-specific IgG levels and mem-
ory B cells. Previous studies on the relationship between antigen-
specific IgG levels andmemory B-cell frequencies, including stud-
ies of P. falciparum-specific responses, have yielded conflicting
results (15, 55–57). In the present study, we did not find convinc-
ing evidence of such a relationship (Fig. 8). While we did observe
a statistically significant relationship between FV6-specific IgG
and the frequency of the corresponding memory B cells (Fig. 8,
middle panel), this relationship depended strongly on two outly-
ing data points, so we caution against making firm conclusions.
FIG 4 Relationship between plasma IgG levels and parity in nonpregnant
Ghanaian women. Parity and IgG levels specific for FV2 (top), FV6 (center),
and FV60 (bottom) in individual donors are shown, as well as the linear re-
gression lines and 95%confidence intervals for their relationship. The negative
cutoff (mean plus 2 SD of levels in negative-control donors) is indicated by
shading. With respect to FV2, nonexposed donors (nulligravidae) are indi-
cated with open symbols.
FIG 5 Frequencies of antigen-specific IgG-secreting B cells in different groups
of women. Frequencies of IgG-secreting B cells in peripheral blood from indi-
vidual P. falciparum-exposed nonpregnant (; E) and parturient (Œ; EP)
women and from nonexposed, nonpregnant women (Œ; N) are shown. Fre-
quencies of B cells secreting IgG specific for the P. falciparum antigens FV2,
FV6, and FV60 and the non-P. falciparum antigen tetanus toxoid (TT) are
shown. The negative cutoff (1 antibody-secreting cell per 1  106 PBMC) is
indicated by shading. Median levels (horizontal lines) are also indicated.
B-Cell Responses to P. falciparum Malaria
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DISCUSSION
Following exposure to blood-borne antigens, short-lived plasma
cells arise rapidly in the red pulp of the spleen, secreting antibodies
thatmay help to control the acute infection. Long-livedmemory B
cells appear later, as a result of the germinal center reaction of
clonal expansion and somatic hypermutation, and these cells can
circulate for months or longer. They act as sentinels that do not
themselves secrete antibody but can initiate a rapid and high-
affinity antibody response upon reinfection. They also give rise to
plasma cells thatmigrate to the bonemarrow, where they reside as
nondividing, antibody-secreting plasma cells for shorter or longer
periods. These terminally differentiated cells are increasingly con-
sidered themain source of specific antibody that can persist in the
blood for very long periods, even in the absence of reexposure or
persistent antigen (54). With respect to P. falciparum malaria, it
has often been proposed that formation and maintenance of im-
munological B-cellmemory are deficient, although the evidence is
far from unequivocal (reviewed in references 2, 3, and 4). Thus, it
has been speculated that continuous or regular exposure to P.
falciparum antigens is required to maintain B-cell memory, but
also that formation of B-cell memory is compromised in areas of
intense parasite transmission (58, 59). Several recent reports indi-
cating the formation of durable B-cell memory following natural
exposure to P. falciparum antigens add to the ambiguity (15–18).
If immunological memory to malaria were indeed defective, it
could undermine the sustainability of recent reductions in para-
site transmission, as it might leave formerly protected individuals
vulnerable if transmission should reappear (60, 61). Also, it could
be an understudied contributing factor to the difficulties in devel-
oping robust vaccines against the disease.
In the present study, we investigated how exposure to P. falcip-
arum antigens, antibody levels, and immunological memory are
related.We used a novel approach designed to remove some of the
shortcomings in earlier studies of the relationship between P. fal-
ciparum antigen-specific antibody levels and frequencies of the
corresponding memory B cells. Specifically, we studied a single
group of P. falciparum-exposed women and compared their re-
sponses to three clinically important, structurally and functionally
similar antigens that are exposed to the immune system in very
different ways. One (FV2) is a VAR2CSA-type PfEMP1 encoded
by var genes that are transcribed and translated only by parasites
infecting pregnant women (62, 63). In contrast, FV6 and FV60 are
encoded by var genes that are transcribed and translated indepen-
dent of pregnancy, and they represent rosetting PfEMP1 proteins
thought to be involved in the pathogenesis of severe malaria in
childhood (31). People living in areas with stable transmission of
P. falciparum parasites are thought to be exposed regularly to par-
asites expressing this type of PfEMP1 proteins (32, 33, 64, 65).
First, we found that levels of circulating IgG specific for the
VAR2CSA-type PfEMP1 FV2 were generally low in nonpregnant,
P. falciparum-exposedwomen, whilemost had significant levels of
FIG 6 Relationship between frequency of IgG-secreting B cells and time since
last pregnancy in nonpregnant Ghanaian women. Times since last pregnancy
and frequencies of IgG antibody-secreting B cells specific for FV2 (top), FV6
(center), and FV60 (bottom) in individual donors are shown, as well as the
linear regression lines and 95% confidence intervals for their relationship. The
negative cutoff (1 antibody-secreting cell per 1  106 PBMC) is indicated by
shading. Note that nulligravidae were excluded from this graph.
Ampomah et al.
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IgG specific for the non-pregnancy-restricted PfEMP1 antigens
FV6 and FV60 (Fig. 1). This fits earlier observations that PfEMP1-
specific antibody responses tend to be transient and require regu-
lar boosting (7) and that IgG to CSA-adherent IEs is generally
absent early in pregnancy (47) and decays within a few months of
delivery (48). Although other authors have reported a high dura-
bility of IgG specific for VAR2CSA-type PfEMP1, the confidence
intervals of their estimates are very wide (66). Furthermore, the
estimates were based on repeated measures among pregnant
women only, although durability is likely to be quite different
during and after pregnancy. In any case, we did not observe the
significant relationship between FV2-specific IgG levels and time
since last pregnancy (Fig. 3). However, this may simply reflect a
lack of statistical power to detect such a relationship, as indicated
by the fact that the proportion of women with measurable
VAR2CSA-specific IgG did decline with time since last pregnancy.
Second, we found a significant relationship between
VAR2CSA-specific IgG and the number of previous pregnancies,
whereas no such relationshipwas seen for IgG specific for PfEMP1
proteins not related to pregnancy (Fig. 4). A relationship between
VAR2CSA-specific IgG and the number of previous pregnancies
among nonpregnant women has not been observed previously,
although it clearly resembles that seen for pregnant women at
term in several earlier reports (reviewed in reference 29). The find-
ing is not self-evident, as the decline in VAR2CSA-specific IgG
levels following delivery discussed above would be expected to
make such a relationship fade within months of delivery—unless
early pregnancies tend to be spaced wider than later ones (thereby
leaving more time for catabolic decay of antibodies), which seems
improbable. Instead, the relationship might reflect a gradually in-
creasing longevity of plasma cells secreting IgG specific for
VAR2CSA-type PfEMP1 over the course of several pregnancies, in
line with the standard antibody response following vaccination
and revaccination (67). Because circulating levels of antibodies
mainly reflect the rate at which they are synthesized, an increased
life span of IgG-secreting cells would lead to more durable anti-
body levels after antigen has been cleared. Indeed, the transition
from short-lived IgG responses in young children (7, 8, 68, 69) to
more durable antibody responses later on (5, 9) may be a more
general instance of this putative change in the longevity of the
antibody-secreting cells. This would provide an alternative or
complementary explanation for the incremental acquisition of
antibodies in areas of seasonal parasite transmission (70), which is
generally attributed to a need for numerous antigen exposures
before solid immunological memory is formed.
Third, we found that the frequencies of memory B cells that
could give rise to antibody-secreting plasma cells following non-
specific induction in vitro were similar for all three PfEMP1 pro-
teins studied, despite marked differences in donor exposure to
these antigens (Fig. 5). This suggests that robust immunological
memory can result evenwhen antigen exposure is infrequent (as is
the case for VAR2CSA). This conclusion is supported by data on
FIG 7 Relationship between frequency of IgG-secreting B cells and parity in
nonpregnant Ghanaian women. Parity and frequencies of IgG antibody-se-
creting B cells specific for FV2 (top), FV6 (center), and FV60 (bottom) in
individual donors are shown, as well as the linear regression lines and 95%
confidence intervals for their relationship. The negative cutoff (1 antibody-
secreting cell per 1 106 PBMC) is indicated by shading.With respect to FV2,
nonexposed donors (nulligravidae) are indicated with open symbols.
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acquisition of immunity in settings with a low level of endemicity,
in travelers, and in experimentally infected mice (17, 59, 71). The
finding that FV2-specific memory B-cell frequencies did not de-
pend on time since last pregnancy (Fig. 6) or number of previous
pregnancies (Fig. 7) is further evidence that fully formed FV2-
specific B-cell memory can be formed in the course of a single
pregnancy and that this memory can be maintained for many
years in the absence of antigen reexposure.
Fourth, we did not find convincing correlations between the
frequencies of antigen-specific memory B cells and levels of the
corresponding antibody specificities in the circulation (Fig. 8).
Previous reports on the relationship between memory B cells and
circulating P. falciparum-specific antibody have yielded ambigu-
ous results (15, 55–57). The underlying assumption of these stud-
ies is that memory B cells are required for antibody production,
considering antibody-secreting plasma cells to be too short-lived
to play amajor role in sustained antibody production (reviewed in
reference 72). However, long-lived, bone-marrow-resident
plasma cells are increasingly regarded as the main source of circu-
lating antibody (54), and there is direct experimental evidence
that long-lived plasma cells can persist for extended periods in the
absence of detectable memory B cells (54). This suggests that the
relationship between circulating memory B cells and circulating
antibody may not be as straightforward as sometimes assumed.
Two final points deserve mention. One is our observation
that a minority of the women who reported that they had not
been pregnant before had FV2-specific IgG (Fig. 2), whereas
FV2-specific memory B-cell frequencies (Fig. 7) above the neg-
ative cutoff were detected in about half of these women. This
was unexpected given the strong evidence that expression of
VAR2CSA-type PfEMP1 is restricted to pregnancy (29). Apart
from the trivial explanation of unrecognized or unremembered
(unsuccessful) pregnancies mentioned above, it remains a pos-
sibility that VAR2CSA-specific immunity can occasionally ap-
pear independent of pregnancy. Indeed, there are a few reports
of significant levels of IgG to VAR2CSA-type PfEMP1 among P.
falciparum-exposed men and children (73). However, the strong
link between parity and susceptibility to placentalmalaria suggests
that pregnancy-independent immune responses to VAR2CSA-
type PfEMP1 do not normally protect against placental malaria.
Functional characterization of VAR2CSA-reactive antibodies in
men, children, and nulligravidae might shed light on this issue.
The other point relates to previous reports that intensive and/or
repeated antigen exposure to malaria antigens can drive expan-
sion of so-called “atypical” memory B cells (14) that may be func-
tionally “exhausted” (13, 74, 75), as has been observed in HIV
infection (76). It has been suggested that this could explain the
paradoxical inverse relationship between parasite exposure and
acquired immunity observed in some studies (58, 59). However,
the antigen specificity of phenotypically identified “atypical”/“ex-
hausted” memory B cells observed in these papers was not estab-
FIG 8 Relationship between frequency of IgG-secreting B cells and plasma
IgG levels in nonpregnant Ghanaian women. Frequencies of IgG antibody-
secreting B cells specific for FV2 (top), FV6 (center), and FV60 (bottom) and
plasma levels of the same IgG in individual donors are shown, as well as the
linear regression lines and 95% confidence intervals for their relationship. The
negative cutoffs are indicated by shading. With respect to FV2, nonexposed
donors (nulligravidae) are indicatedwith open symbols.Note the scaling of the
axes.
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lished, and other recent studies did not find evidence that B-cell
memory for P. falciparum antigens is deficient (16, 17) or that
“atypical” P. falciparum-specific B cells are dysfunctional (18).
Careful studies of the phenotype-function relationships among
B-cell subsets with known antigen specificity are clearly war-
ranted.
In conclusion, our study provides evidence that natural expo-
sure to P. falciparum parasites leads to induction of immunologi-
cal B-cell memory for clinically important PfEMP1 antigens, even
when antigen exposure is infrequent. Furthermore, we provide
evidence that this memory can be maintained for long periods
after antigen exposure has ceased, and after circulating antibody is
no longer detectable. This bodes well for the sustainability of ef-
forts to eliminate and eradicate P. falciparum and for current ef-
forts to develop malaria vaccines in general, and PfEMP1-based
vaccines in particular.
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